Article
EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
Lung cancer (Amsterdam, Netherlands) - 1 Jun 2016
Créquit Perrine, Ruppert Anne-Marie, Rozensztajn Nathalie, Gounant Valérie, Vieira T, Poulot Virginie, Antoine Martine, Chouaid Christos, Wislez Marie, Cadranel Jacques, Lavole Armelle
Abstract excerpt
Non-small-cell lung cancer (NSCLC) is the most common non-acquired immune deficiency syndrome-related malignancy responsible for death. Mutational status is crucial for choosing treatment of advanced NSCLC, yet no data is available on the frequency of epidermal growth factor receptor (EGFR) and Kirsten ras (KRAS) mutations and their impact on NSCLC in human immunodeficiency virus (HIV)-infected patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
